Insider Cluster (5 insiders) ·Filed Jun 15, 2026

ABEO

ABEONA THERAPEUTICS INC.
BEARISH
Impact 5/10
Horizonweeks Processed3mo ago
Insider cluster: 5 insiders, $0.4M total
Actionable Insight ▼ Bearish

The simultaneous open-market sales by the CEO, CFO, CCO, and CLO on the same day (June 9) is an unusually coordinated signal. While the dollar amount is modest, the breadth of C-suite participation warrants caution. Monitor for any upcoming news (earnings, pipeline update, financing) that may have prompted this cluster. The cross-filing calibration amplifies this cluster's significance.

DirectionBearish
Confidencemedium
Horizonweeks
Latest settled — T+20d ⚠ clustered
ABEO ▲ +24.96% at T+20d
SHORT call ✗ call lost -24.96% · α vs SPY -24.76% · entry $5.65 → $7.06
Next anchor: T+60d due 22d ago
Latest observation: T+57 -8.42% FF3 residual α
Entry anchored
Jun 15, 03:59 PM ET
via exchange tick
T+1d
0.00%
call 0.00% · α -1.25%
$5.65
settled 4mo ago
T+5d
+1.24%
call -1.24% · α -3.47%
$5.72
settled 3mo ago
T+20d
+24.96%
call -24.96% · α -24.76%
$7.06
settled 3mo ago
T+60d
—
call — · α —
—
due 22d ago

Price Chart

Loading chart...

Executive Summary

Five ABEO insiders, including the CEO and CFO, sold a total of $407K in open-market sales over a 7-day window. The cluster is concentrated on June 9, with the CEO alone selling $169K. While the dollar amount is modest relative to the $315M market cap (0.13%), the participation of the entire C-suite (CEO, CFO, CCO, CLO) on the same day is notable and amplifies the signal per the cross-filing calibration.

Key Financial Metrics

Direction
selling
Total Value
$407.0K
Insiders
5

Key Facts

  • CEO Vishwas Seshadri sold 31,916 shares for $169K on June 9.
  • CFO Joseph Vazzano sold 13,421 shares for $71K on June 9.
  • CCO Madhav Vasanthavada sold 5,450 shares for $29K on June 9.
  • CLO Brendan O'Malley sold 6,305 shares for $33K on June 9.
  • Director Christine Silverstein sold 18,160 shares for $104K on June 15.
  • Total cluster value: $407K, representing 0.13% of market cap.
  • All sales were open-market (code S); no 10b5-1 plan context provided.

Financial Impact

Total insider sales of $407K, or 0.13% of $315M market cap.

insider ownershipmarket sentiment

Risk Factors

  • Potential negative catalyst (e.g., clinical trial setback, financing need) that insiders may be anticipating.
  • Further insider selling could pressure the stock.
  • Lack of 10b5-1 plan disclosure increases the likelihood of discretionary, potentially informed, selling.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
92% bullish (12 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-ABEO-1781567345178
19 reports for ABEO
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for ABEO — sortable, filterable
TypeNow
Sep 15, 2026
17d ago
8-K
NEUTRAL ★ 2/10
$5.47 $5.57▲ +1.83%▲ +1.01%$5.03 (−8.14%)
Aug 14, 2026
6w ago
Institutional Cluster
BULLISH ★ 5/10
$5.94 $6.06▲ +2.02%▲ +3.21%$5.03 (−15.40%)
Aug 13, 2026
7w ago
8-K
NEUTRAL ★ 5/10
$6.35 $5.96▼ −6.07%▼ −4.10%$5.03 (−20.80%)
Aug 13, 2026
7w ago
Press Release
MIXED ★ 6/10
$6.35 $5.96▼ −6.07%▼ −4.10%$5.03 (−20.80%)
Jul 9, 2026
12w ago
Insider Cluster
NEUTRAL ★ 2/10
$6.98 $7.02▲ +0.57%▲ +1.13%$5.03 (−28.01%)
Jun 15, 2026
15w ago
Insider Cluster
NEUTRAL ★ 4/10
$5.65 $5.72▲ +1.24%▲ +3.47%$5.03 (−11.06%)
Jun 15, 2026
15w ago
Insider Cluster
BEARISH ★ 5/10
$5.65 $5.72▼ −1.24%▼ −3.47%$5.03 (+11.06%)
Jun 12, 2026
16w ago
8-K
NEUTRAL ★ 2/10
$5.53 $5.77▲ +4.34%▲ +3.67%$5.03 (−9.13%)
Jun 10, 2026
16w ago
8-K
NEUTRAL ★ 2/10
$5.53 $5.65▲ +2.17%▲ +1.74%$5.03 (−9.13%)
Jun 10, 2026
16w ago
Insider Cluster
BEARISH ★ 5/10
$5.36 $5.65▼ −5.41%▼ −1.98%$5.03 (+6.25%)
Showing 10 of 19

US Market Status

Market Open — Closes in 2h 17m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Jun 15, 2026